Switch Bioworks
PrivateLast Round
Grant
Jan 16, 2025
Total Funding Raised
$23.93M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Switch Bioworks is a biotechnology company that engineers microbes to create sustainable biofertilizers, transforming them into mini-factories that produce fertilizers directly at plant roots.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Switch Bioworks Comparables
Compare Switch Bioworks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Azotic Technologies Limited | 87% | |
| Kula Bio | 87% | |
| Pivot Bio | 81% |
Switch Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 16, 2025 | ||||
| Seed | Sep 5, 2024 | ||||
| Grant | Jul 1, 2024 | ||||
| Pre Seed | May 25, 2022 |
Key People
Founding team and executive leadership
Switch Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Astanor Ventures | Seed |
| Grantham Foundation for the Protection of the Environment | Seed |
| Acre Venture Partners | Seed, Pre Seed |
| The Grantham Foundation for the Protection of the Environment | Seed |
| ACRE | Pre Seed |
| Bill & Melinda Gates Foundation | Grant |
| Ag Ventures Alliance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 56% MoM.
- Aug 7, 2025
Tripled R&D footprint with move to San Carlos, CA.
Recent news
Latest coverage and updates
- partners_withOct 20, 2026
Switch Bioworks, Inc. and Bayer AG announce a strategic agreement focused on advancing microbial technologies for biological nitrogen fixation, crop nutrition, and nutrient-use efficiency on Oct 20th '26.
- is_developingOct 19, 2026
Switch Bioworks, Inc. partners with Bayer on genetic switch technology for next-generation biofertilisers, initially targeting nitrogen fixation.
- is_developingOct 19, 2026
Switch Bioworks, Inc. plans to develop Nitrogen Fixation Solutions For Crops with Bayer, as reported on Oct 19th '26.
- is_developingOct 15, 2026
On Oct 15th '26, California-based Switch Bioworks, Inc. announces a research partnership with Bayer Crop Science to develop microbial fertilizers, initially focusing on nitrogen production for crops; field trials are underway at several Midwest locations.
- partners_withOct 13, 2026
Switch Bioworks, Inc. partners with Bayer AG on genetic switch technology to develop next-generation biologicals, with nitrogen fixation as an initial focus, in California on Oct 13th '26.
Switch Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Switch Bioworks's valuation, stock price, and market status.
Is Switch Bioworks a public or private company?
Switch Bioworks is a private company.
What is the current stock price of Switch Bioworks?
Switch Bioworks is a private company, so its shares have no public market price. Caplight tracks Switch Bioworks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Switch Bioworks worth (valuation)?
Valuation information for Switch Bioworks is not publicly available.
Can I buy Switch Bioworks stock?
Switch Bioworks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Switch Bioworks's last funding round?
Switch Bioworks's most recent funding round was Grant on January 16, 2025.
Who are the main investors in Switch Bioworks?
Key investors in Switch Bioworks include Acre Venture Partners, Bill & Melinda Gates Foundation, Anthos Capital.
Will Switch Bioworks IPO soon?
No public IPO plans have been announced for Switch Bioworks.
How can I track Switch Bioworks secondary market activity?
Caplight tracks bids, offers, and trades in Switch Bioworks's shares on secondary markets.